Table 1 Clinical characteristics of the bladder cancer patients
Expression of ERBB3 | |||||
|---|---|---|---|---|---|
Low | High | ||||
No. of patients | % | No. of patients | % | P -value | |
Total | 12 | 47 | |||
Age | |||||
<69 | 6 | 50.0 | 22 | 46.8 | 0.843 |
≥69 | 6 | 50.0 | 25 | 53.2 | |
Gender | |||||
Male | 9 | 75.0 | 41 | 87.2 | 0.547 |
Female | 3 | 25.0 | 6 | 12.8 | |
Tumor grade | |||||
Low | 0 | 0 | 3 | 6.5 | 1.000 |
High | 12 | 100.0 | 43 | 93.5 | |
Tumor stage | |||||
I–II | 6 | 50.0 | 22 | 47.8 | 0.893 |
III–IV | 6 | 50.0 | 24 | 52.2 | |
Lymph node invasion | |||||
Yes | 0 | 0 | 7 | 20.6 | 0.177 |
No | 10 | 100 | 27 | 79.4 | |
DNMT1 | |||||
High | 4 | 33.3 | 22 | 47.8 | 0.567 |
Low | 8 | 66.7 | 24 | 52.2 | |
miR-148a-3p | |||||
High | 7 | 58.3 | 26 | 55.3 | 0.851 |
Low | 5 | 41.7 | 21 | 44.7 | |
